Search

Vishal Verma

from Henderson, NV
Age ~47

Vishal Verma Phones & Addresses

  • 832 Sandhill Sage St, Henderson, NV 89052
  • New York, NY
  • Las Vegas, NV
  • Jersey City, NJ
  • Iselin, NJ
  • Philadelphia, PA

Professional Records

License Records

Vishal Verma

Address:
10155 W Twain Ave , No 110, Las Vegas, NV 89147
License #:
B01535 - Active
Issued Date:
Jan 17, 2014
Expiration Date:
Dec 31, 2018

Medicine Doctors

Vishal Verma Photo 1

Dr. Vishal Verma, Brooklyn NY - MD (Doctor of Medicine)

View page
Specialties:
Internal Medicine
Address:
BROOKLYN HOSPITAL CENTER
121 Dekalb Ave, Brooklyn, NY 11201
(718) 250-8000 (Phone), (718) 250-6124 (Fax)

Ambulatory Internal Medicine
10615 N Hayden Rd Suite 100, Scottsdale, AZ 85260
(480) 998-3990 (Phone)

Southside Phys Ntwrk Hsptlsts
200 Medical Park Blvd, Petersburg, VA 23805
(804) 765-5991 (Phone)
Languages:
English
Hospitals:
BROOKLYN HOSPITAL CENTER
121 Dekalb Ave, Brooklyn, NY 11201

Southside Phys Ntwrk Hsptlsts
200 Medical Park Blvd, Petersburg, VA 23805

Ambulatory Internal Medicine
10615 N Hayden Rd Suite 100, Scottsdale, AZ 85260

Brooklyn Hospital Center at Downtown
121 Dekalb Avenue, Brooklyn, NY 11201
Vishal Verma Photo 2

Vishal Verma, New York NY - LAC

View page
Specialties:
Acupuncture
Address:
130 5Th Ave, New York, NY 10011
(206) 618-6230 (Phone)
Languages:
English
Vishal Verma Photo 3

Vishal Verma

View page
Specialties:
Radiology
Work:
Stat Radiology
13280 Evening Crk Dr S STE 110, San Diego, CA 92128
(858) 546-3800 (phone), (858) 546-3900 (fax)
Education:
Medical School
University of Miami, Miller School of Medicine
Graduated: 1998
Languages:
English
Description:
Dr. Verma graduated from the University of Miami, Miller School of Medicine in 1998. He works in San Diego, CA and specializes in Radiology.
Vishal Verma Photo 4

Vishal Verma, Brooklyn NY

View page
Specialties:
Internal Medicine
Work:
The Brooklyn Hospital
121 Dekalb Ave, Brooklyn, NY 11201
Southside Hospitalist Group
200 Medical Park Blvd, Petersburg, VA 23805
Education:
Kasturba Medical College Manipal

Resumes

Resumes

Vishal Verma Photo 5

Vishal Verma Hicksville, NY

View page
Work:
SELF-EMPLOYED

2012 to 2000
Independent Consultant - Software & Website Development

BROADWAY NATIONAL SIGN & LIGHTING
Ronkonkoma, NY
2013 to 2015
Director of Software Development

INFOSLATE, INC
Oyster Bay, NY
2008 to 2012
Chief Technology Officer

THOMSON-REUTERS, INC

2006 to 2008
Research Scientist, Media Research & Development

THOMSON-REUTERS, INC
New York, NY
2001 to 2008

THOMSON-REUTERS, INC

2003 to 2006
Programmer Analyst

THOMSON-REUTERS, INC

2001 to 2003
Programmer Analyst, Reuters

MUSIC SOFTWARE INC
Roslyn, NY
1992 to 2001
Senior Engineer

Education:
State University of New York at Stony Brook
Stony Brook, NY
1997 to 2003
Bachelor's in Computer Science

Vishal Verma Photo 6

Vishal Verma

View page
Work:
SIEL Chemical Complex

Mar 2014 to 2000
Asst Manager-II

Abhitech Energycon Ltd

Oct 2009 to Feb 2014
Asst Sales Manager

Bharti Airtel Limited

Jul 2007 to Aug 2009
BDM

Education:
Institute & University
2007
MBA in Marketing

HPU
Shimla, Himachal Pradesh
2001 to 2005
B.Sc in Chemistry

Skills:
Industrial Sales,Institutional sales,Corporate sales,Direct Marketing Etc.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Vishal Verma
AndroidBean
Delivery Service · Internet Service
250 W 40 St 8 Floor, New York, NY 10018
(212) 398-0780

Publications

Us Patents

Substituted Pyridine And Pyrimidine Derivatives And Their Use In Treating Viral Infections

View page
US Patent:
20110318305, Dec 29, 2011
Filed:
Aug 19, 2009
Appl. No.:
13/059193
Inventors:
Ashok Arasappan - Bridgewater NJ, US
F. George Njoroge - Warren NJ, US
Cecil D. Kwong - Birmingham AL, US
Subramaniam Ananthan - Birmingham AL, US
Frank Bennett - Cranford NJ, US
Jeremy Clark - Birmingham AL, US
Vinay M. Girijavallabhan - Denville NJ, US
Yuhua Huang - Westfield NJ, US
Regina Huelgas - New York NY, US
Joseph A. Maddry - Birmingham AL, US
John J. Piwinski - Lebanon NJ, US
Robert C. Reynolds - Birmingham AL, US
Abhijit Roychowdhury - Birmingham AL, US
Anita T. Fowler - Irondale AL, US
Feng Geng - Piscataway NJ, US
Neng-Yang Shih - Lexington MA, US
Vishal Verma - Jersey City NJ, US
Francisco Velazquez - Clinton NJ, US
Srikanth Venkatraman - Edison NJ, US
International Classification:
A61K 31/506
C07D 413/14
A61P 31/12
A61K 38/21
A61K 39/00
A61K 39/42
C07D 407/14
A61K 31/5377
US Classification:
424 854, 544324, 514275, 544122, 5142338, 51421021, 4241841, 4241591
Abstract:
The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R, X, Y, Z, R, R, R, R, R, R, R, R, R, Rand n is selected independently and as defined herein. Compositions comprising such compounds are also provided. The compounds of the invention are effective as inhibitors of HCV, and are useful, alone and together with other therapeutic agents, in treating or preventing diseases or disorders such as viral infections and virus-related disorders.

Substituted Pyridine And Pyrimidine Derivatives And Their Use In Treating Viral Infections

View page
US Patent:
20140242027, Aug 28, 2014
Filed:
Feb 18, 2011
Appl. No.:
13/579399
Inventors:
Ashok Arasappan - Rahway NJ, US
F. George Njoroge - Carmel IN, US
Cecil D. Kwong - Homewood AL, US
Subramaniam Ananthan - Birmingham AL, US
Frank Bennett - Cranford NJ, US
Francisco Velazquez - Clinton NJ, US
Vinay Girijavallabhan - Denville NJ, US
Yuhua Huang - Westfield NJ, US
Hollis S. Kezer - Hoover AL, US
Joseph Maddry - Birmington AL, US
Robert C. REynold - Birmington AL, US
Abhijit Roychowdhury - Homewood AL, US
Anita T. Fowler - Irondale AL, US
Ling Tong - Warren NJ, US
Seong Heon Kim - Livington NJ, US
Malcolm MacCoss - Seabrook island SC, US
Srikanth Venkatraman - Edison NJ, US
vishal Verma - Jersey City NJ, US
Assignee:
Southern Research Institute - Birmingham AL
Merck Sharp & Dohne Corp. - Rahway NJ
International Classification:
C07D 513/04
C07D 417/04
A61K 45/06
C07D 417/14
C07D 491/048
A61K 31/506
US Classification:
424 854, 544324, 514275, 514 44 A, 4241841, 4241591, 544230, 51421021
Abstract:
The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R, X, Y, Z, R, R, R, R, R, R, R, R, R, Rand n is selected independently and as defined herein. Compositions comprising such compounds are also provided. The compounds of the invention are effective as inhibitors of HCV, and are useful, alone and together with other therapeutic agents, in treating or preventing diseases or disorders such as viral infections and virus-related disorders.

5'-Substituted Nucleoside Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases

View page
US Patent:
20140235567, Aug 21, 2014
Filed:
Jul 10, 2012
Appl. No.:
14/232540
Inventors:
Vishal A. Verma - Jersey City NJ, US
Ashok Arasappan - Bridgewater NJ, US
F. George Njoroge - Carmel IN, US
Vinay Girijavallabhan - Denville NJ, US
Stephane L. Bogen - Somerset NJ, US
Qun Dang - Westfield NJ, US
David B. Olsen - Lansdale PA, US
International Classification:
C07H 19/14
A61K 45/06
A61K 31/7056
A61K 31/7064
US Classification:
514 49, 536 272, 536 267
Abstract:
The present invention relates to 5′-Substituted Nucleoside Derivatives of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein B, X, Y, Z, R, R, Rand R are as defined herein. The present invention also relates to compositions comprising at least one 5′-Substituted Nucleoside Derivative, and methods of using the 5′-Substituted Nucleoside Derivatives for treating or preventing HCV infection in a patient.

5'-Substituted Nucleoside Analogs And Methods Of Use Thereof For The Treatment Of Viral Diseases

View page
US Patent:
20140221304, Aug 7, 2014
Filed:
Jul 10, 2012
Appl. No.:
14/232536
Inventors:
Vishal A. Verma - Jersey City NJ, US
Ashok Arasappan - Bridgewater NJ, US
F. George Njoroge - Carmel IN, US
Kevin X. Chen - Edison NJ, US
International Classification:
C07H 19/06
C07H 19/16
C07H 19/20
A61K 31/7056
A61K 31/7072
A61K 31/708
A61K 31/7076
A61K 45/06
C07H 19/10
A61K 31/7068
US Classification:
514 48, 536 285, 536 268, 536 2853, 536 2851, 536 2781, 536 267, 514 49, 514 50, 514 51, 514 45
Abstract:
The present invention relates to 5′-Substituted Nucleoside Analogs of Formula (I): and pharmaceutically acceptable salts thereof, wherein B, X, Z, R, R, Rand R are as defined herein. The present invention also relates to compositions comprising at least one 5′-Substituted Nucleoside Analog, and methods of using the 5′-Substituted Nucleoside Analogs for treating or preventing HCV infection in a patient.

2'-Cyano Substituted Nucleoside Derivatives And Methods Of Use Thereof Useful For The Treatment Of Viral Diseases

View page
US Patent:
20140161770, Jun 12, 2014
Filed:
Apr 11, 2012
Appl. No.:
14/111688
Inventors:
Vinay Girijavallabhan - Whippany NJ, US
F. George Njoroge - Carmel IN, US
Stephane Bogen - Somerset NJ, US
Angela Kerekes - Plainfield NJ, US
Frank Bennett - Cranford NJ, US
Ying Huang - Berkeley Heights NJ, US
Latha Nair - Edison NJ, US
Dmitri Pissarnitski - Scotch Plains NJ, US
Vishal Verma - South San Francisco CA, US
Qun Dang - Westfield NJ, US
Ian Davies - Princeton NJ, US
David B. Olsen - Lansdale PA, US
Andrew Stamford - Chatham NJ, US
Joseph P. Vacca - Telford PA, US
Assignee:
MERCK SHARP & DOHME CORP. - Rahway NJ
International Classification:
C07H 19/16
A61K 31/7076
A61K 45/06
C07H 19/20
C07H 19/10
C07H 19/06
A61K 31/7056
A61K 31/7068
US Classification:
424 857, 514 48, 514 49, 514 51, 536 2612, 536 2614, 536 267, 536 268
Abstract:
The present invention relates to 2′-Cyano Substituted Nucleoside Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein B, X, R, Rand Rare as defined herein. The present invention also relates to compositions comprising at least one 2′-Cyano Substituted Nucleoside Derivative, and methods of using the 2′-Cyano Substituted Nucleoside Derivatives for treating or preventing HCV infection in a patient.

2'-Substituted Nucleoside Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases

View page
US Patent:
20140154211, Jun 5, 2014
Filed:
Apr 11, 2012
Appl. No.:
14/111687
Inventors:
Vinay Girijavallabhan - Kenilworth NJ, US
F. George Njoroge - Carmel IN, US
Stephane Bogen - Somerset NJ, US
Vishal Verma - San Francisco CA, US
Frank Bennett - Cranford NJ, US
Angela Kereles - Plainfield NJ, US
Ashok Arasappan - Bridgewater NJ, US
Dmitri Pissarnitski - Scotch Plains NJ, US
Qun Dang - Westfield NJ, US
Ian Davies - Princeton NJ, US
David B. Olsen - Lansdale PA, US
Andrew Stamford - Chatham NJ, US
Joseph P. Vacca - Telford PA, US
International Classification:
A61K 31/7072
A61K 31/7068
A61K 45/06
C07H 17/02
US Classification:
424 857, 536 285, 514 49, 536 2781, 514 45, 536 2853, 514 50, 536 268, 536 267, 514 48, 536 2614, 536 2612, 536 2626
Abstract:
The present invention relates to 2′-Substituted Nucleoside Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, X, R, Rand Rare as defined herein. The present invention also relates to compositions comprising at least one 2′-Substituted Nucleoside Derivative, and methods of using the 2′-Substituted Nucleoside Derivatives for treating or preventing HCV infection in a patient.
Vishal Verma from Henderson, NV, age ~47 Get Report